Review: Preclinical Data and Unmet Needs for Obesity Therapeutics
Perspectives from three obesity specialists regarding our imminent CBeyond Phase 2a clinical trial data and new preclinical results.
Skye’s CEO and CMO get perspectives from three obesity specialists regarding our imminent CBeyond Phase 2a clinical trial data and new preclinical results.